TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32899117

Group type: EXPERIMENTAL
Intervention: Exosomes from night shift (NS) condition
Number of subjects: 14

Group type: COMPARATOR
Intervention: Exosomes from day shift (DS) condition
Number of subjects: 14
Study: 34338733

Group type: EXPERIMENTAL
Intervention: Miniscrews
Number of subjects: 24

Group type: COMPARATOR
Intervention: Essix appliance
Number of subjects: 24
Study: 32096902

Group type: EXPERIMENTAL
Intervention: Percutaneous Mastoid Electrical Stimulator (PMES) daily for 45 minutes for three months
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Supraorbital Transcutaneous Stimulator (STS) daily for 20 minutes for three months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Supraorbital Transcutaneous Stimulator (STS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Percutaneous Mastoid Electrical Stimulator (PMES)
Number of subjects: 90
Study: 36323056

Group type: EXPERIMENTAL
Intervention: Digital single-session intervention teaching malleability beliefs about personal traits and symptoms (growth mindset)
Number of subjects: 638
Study: 34461298

Group type: EXPERIMENTAL
Intervention: Care coordination intervention (proactive symptom monitoring and care coordinator-triggered algorithms)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205
Study: 34158253

Group type: EXPERIMENTAL
Intervention: Exercise during NACRT and unsupervised exercise after NACRT
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 36
Study: 32278346

Group type: EXPERIMENTAL
Intervention: Intramuscular glucocorticoid injection (40 mg triamcinolone acetonide)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Intra-articular glucocorticoid injection (40 mg triamcinolone acetonide)
Number of subjects: 140
Study: 35672525

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 33858221

Group type: EXPERIMENTAL
Intervention: Eight-session single-family intervention to improve individual and family functioning
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (rehabilitation at a specialised traumatic brain injury outpatient clinic)
Number of subjects: 61
Study: 34637645

Group type: EXPERIMENTAL
Intervention: 2min‐130% ‐ FATmax
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 20s:10s‐170% ‐ FATmax
Number of subjects: 12

Group type: COMPARATOR
Intervention: FATmax
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-intensity bouts
Number of subjects: 12
Study: 33843566

Group type: EXPERIMENTAL
Intervention: Warning condition (health warning present)
Number of subjects: 1064

Group type: COMPARATOR
Intervention: No Warning condition (health warning absent)
Number of subjects: 1064
Study: 33874964

Group type: EXPERIMENTAL
Intervention: Chiropractic care for 2 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 200
Study: 32503606

Group type: EXPERIMENTAL
Intervention: ActWELL lifestyle intervention programme
Number of subjects: 0
Study: 33607979

Group type: EXPERIMENTAL
Intervention: Pedometer driven walking program (WG) for 12 weeks, guided by a physiotherapist
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Pedometer driven walking program (WG) for 12 weeks
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standardized care group (SG)
Number of subjects: 174
Study: 32618245

Group type: EXPERIMENTAL
Intervention: Mass Drug Administration (MDA)
Number of subjects: 2026

Group type: COMPARATOR
Intervention: focal Mass Drug Administration (fMDA)
Number of subjects: 2026

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 2026
Study: 34762845

Group type: EXPERIMENTAL
Intervention: PROCUIDA-Demencia intervention (2-day staff training program)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 55
Study: 33233020

Group type: EXPERIMENTAL
Intervention: Contingency management (CM) intervention, 5-week escalating with reset; adjunct to standard smoking cessation treatment.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard smoking cessation treatment (control group not explicitly detailed).
Number of subjects: 40
Study: 33372185

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35170727

Group type: EXPERIMENTAL
Intervention: Oligo/Amen + Cal
Number of subjects: 76

Group type: COMPARATOR
Intervention: Oligo/Amen Control
Number of subjects: 76
Study: 33658261

Group type: EXPERIMENTAL
Intervention: Telehealth intervention with weekly calls from registered dietitian nutritionists using motivational interviewing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-directed lifestyle intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 0
Study: 32913018

Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly
Number of subjects: 1890

Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly
Number of subjects: 1890
Study: 35361446

Group type: EXPERIMENTAL
Intervention: Optimal guideline-directed medical therapy (GDMT) including beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and mineralocorticoid receptor antagonists
Number of subjects: 879

Group type: EXPERIMENTAL
Intervention: Optimal GDMT triple therapy use
Number of subjects: 879
Study: 32859257

Group type: EXPERIMENTAL
Intervention: Calamansi drink
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 10
Study: 34864480

Group type: EXPERIMENTAL
Intervention: Prosocial behaviour (donating money to preferred charities)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Non-prosocial behaviour (neutral number judgement task or proself task)
Number of subjects: 180
Study: 32178334

Group type: EXPERIMENTAL
Intervention: Body Appreciation Scale‐2 (BAS‐2‐LT)
Number of subjects: 1412
Study: 34284152

Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Take Control (TC)
Number of subjects: 60
Study: 33818752

Group type: EXPERIMENTAL
Intervention: Shear wave elastography (SWE)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Ultrasonography (US)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic (ROC) curve analysis
Number of subjects: 69
Study: 34088228

Group type: EXPERIMENTAL
Intervention: Family old age care
Number of subjects: 1553

Group type: EXPERIMENTAL
Intervention: Combination of family old age care plus community old age care
Number of subjects: 1553

Group type: EXPERIMENTAL
Intervention: Health-related services demands
Number of subjects: 1553

Group type: EXPERIMENTAL
Intervention: Hospital as care service provider
Number of subjects: 1553

Group type: EXPERIMENTAL
Intervention: Preference for long-term care and emergency call
Number of subjects: 1553
Study: 35485295

Group type: EXPERIMENTAL
Intervention: Ceramic liner
Number of subjects: 53

Group type: COMPARATOR
Intervention: Polyethylene liner
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 34965635

Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shock wave therapy with centrifugal exercise
Number of subjects: 53

Group type: COMPARATOR
Intervention: Centrifugal exercise alone
Number of subjects: 53
Study: 34555421

Group type: EXPERIMENTAL
Intervention: 1-visit retreatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2-visit retreatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (2-visit retreatment)
Number of subjects: 40
Study: 32407535

Group type: EXPERIMENTAL
Intervention: MF59‐adjuvanted vaccine (FLUAD; Seqirus)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High‐dose vaccine (Fluzone High‐Dose; Sanofi Pasteur)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard‐dose inactivated influenza vaccine (FluQuadri; Sanofi Pasteur)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant hemagglutinin vaccine (Flublok; Sanofi Pasteur)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All vaccines
Number of subjects: 0
Study: 35797065

Group type: EXPERIMENTAL
Intervention: Motor imagery combined with structured progressive circuit class therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Health education combined with structured progressive circuit class therapy
Number of subjects: 40
Study: 33910607

Group type: EXPERIMENTAL
Intervention: Photographic assessment of pressure ulcers
Number of subjects: 2029

Group type: EXPERIMENTAL
Intervention: Blinded central review using photographs
Number of subjects: 2029

Group type: EXPERIMENTAL
Intervention: Assessment of skin classification
Number of subjects: 2029
Study: 32548283

Group type: EXPERIMENTAL
Intervention: Adherent image quality MRI
Number of subjects: 990

Group type: COMPARATOR
Intervention: Non-adherent image quality MRI
Number of subjects: 990
Study: 33941192

Group type: EXPERIMENTAL
Intervention: Evolocumab (140 mg every two weeks or 420 mg monthly)
Number of subjects: 585
Study: 35003321

Group type: EXPERIMENTAL
Intervention: Apixaban therapy (research group)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Standard anticoagulation therapy (standard group)
Number of subjects: 157
Study: 36045371

Group type: EXPERIMENTAL
Intervention: Escherichia coli-derived recombinant human bone morphogenetic protein-2 (rhBMP-2) combined with hydroxyapatite (HA)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Auto-iliac bone graft
Number of subjects: 154
Study: 33249220

Group type: EXPERIMENTAL
Intervention: Midazolam-assisted sedation (Group A)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Fentanyl plus midazolam-assisted sedation (Group B)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 106
Study: 32634172

Group type: EXPERIMENTAL
Intervention: Crew size of 2
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Crew size of 3
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Crew size of 4
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Crew size of 5
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Crew size of 6
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Troubleshooting of M-CPR machine
Number of subjects: 140
Study: 34972714

Group type: EXPERIMENTAL
Intervention: Fourier-transform infrared spectroscopy and mathematical simulation models
Number of subjects: 56
Study: 33626041

Group type: EXPERIMENTAL
Intervention: Complex milk lipid-enhanced (CML-E) group - same formulation enriched with complex milk lipids (≥8 mg gangliosides/day)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control - received standard powdered milk formulation (≥4 mg gangliosides/day)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Reference - received no milk
Number of subjects: 1500
Study: 32037653

Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 6969

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6969
Study: 34251840

Group type: EXPERIMENTAL
Intervention: Expectancy + Drug (told active CBD - given active CBD)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Drug (told inactive - given active CBD)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Expectancy (told active CBD - given inactive)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (told inactive - given inactive)
Number of subjects: 15
Study: 33826277

Group type: EXPERIMENTAL
Intervention: Nurse-led intradialytic exercise program for 16 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Home-based exercise program supervised by physical therapists for 16 weeks
Number of subjects: 71
Study: 34228956

Group type: EXPERIMENTAL
Intervention: High-intensity training (HIT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 44
Study: 35770597

Group type: EXPERIMENTAL
Intervention: Remote acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local acupuncture
Number of subjects: 60
Study: 35752839

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional lecture
Number of subjects: 81

Group type: COMPARATOR
Intervention: Before intervention
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: After VR training
Number of subjects: 81
Study: 32713741

Group type: EXPERIMENTAL
Intervention: Natural American Spirit (NAS) cigarettes
Number of subjects: 1003

Group type: COMPARATOR
Intervention: Pall Mall cigarettes
Number of subjects: 1003
Study: 35763390

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU per day
Number of subjects: 635
Study: 34605057

Group type: EXPERIMENTAL
Intervention: Collagen Matrix (CMX)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (CTG)
Number of subjects: 60
Study: 32493111

Group type: EXPERIMENTAL
Intervention: Dorsal web space steroid injection
Number of subjects: 160

Group type: COMPARATOR
Intervention: Palmar midline steroid injection
Number of subjects: 160
Study: 35486014

Group type: EXPERIMENTAL
Intervention: Warming and promoting technique of acupuncture combined with extracorporeal shock wave
Number of subjects: 96

Group type: COMPARATOR
Intervention: Even-needling technique of acupuncture combined with extracorporeal shock wave
Number of subjects: 96
Study: 32867875

Group type: EXPERIMENTAL
Intervention: High-protein egg-based recipes and herb/spice packets
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no recipes or packets)
Number of subjects: 100
Study: 33663073

Group type: EXPERIMENTAL
Intervention: Simplified individualized RCA protocol with high‐flux dialyzer
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Simplified individualized RCA protocol with low‐flux dialyzer
Number of subjects: 45

Group type: COMPARATOR
Intervention: Modified conventional RCA protocol with low‐flux dialyzer
Number of subjects: 45
Study: 32682793

Group type: EXPERIMENTAL
Intervention: Reciproc Blue (RB) 40/.06 file in reciprocating motion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ProDesign Logic (PDL) 40/.01 and 40/.05 files in rotary motion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Flatsonic ultrasonic tip
Number of subjects: 24
Study: 34619001

Group type: EXPERIMENTAL
Intervention: 20% urea cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10% urea cream
Number of subjects: 40
Study: 32107265

Group type: EXPERIMENTAL
Intervention: C-IDM intervention package (including disease targeting management, express referral channel, expert visit, patients' self-management) plus usual care
Number of subjects: 1095

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1095

Group type: EXPERIMENTAL
Intervention: C-IDM intervention package
Number of subjects: 1095
Study: 33449944

Group type: EXPERIMENTAL
Intervention: Mobile Stroke Units (MSU)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard management of tPA-eligible acute stroke patients
Number of subjects: 57
Study: 32399662

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 28

Group type: COMPARATOR
Intervention: oGLD (intensive therapy using other glucose-lowering drugs)
Number of subjects: 28
Study: 33901859

Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy (ET plus MT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Exercise therapy (ET)
Number of subjects: 80
Study: 34035092

Group type: EXPERIMENTAL
Intervention: Medical assistance in dying for patients with low socioeconomic status (SES)
Number of subjects: 50096

Group type: COMPARATOR
Intervention: Medical assistance in dying for patients with high socioeconomic status (SES)
Number of subjects: 50096

Group type: EXPERIMENTAL
Intervention: Odds of receiving medical assistance in dying associated with low socioeconomic status
Number of subjects: 50096
Study: 32580813

Group type: EXPERIMENTAL
Intervention: Medium-GAA (0.6 g/kg DM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High-GAA (0.9 g/kg DM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GAA addition (0.3, 0.6, 0.9 g/kg DM)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Medium-GAA (0.6 g/kg DM) and High-GAA (0.9 g/kg DM)
Number of subjects: 48
Study: 35385094

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32770262

Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 0
Study: 36323488

Group type: EXPERIMENTAL
Intervention: Tuberculin skin test (TST)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Hepatitis B virus (HBV) monitoring
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Biological DMARDs treatment
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Prophylaxis treatment for Pneumocystis jirovecii
Number of subjects: 194
Study: 32854996

Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP) algorithm for detecting PJI
Number of subjects: 2396

Group type: EXPERIMENTAL
Intervention: NLP algorithm for extracting specific PJI diagnostic elements
Number of subjects: 2396
Study: 34392277

Group type: EXPERIMENTAL
Intervention: 3D-printed orthosis (3O)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional orthosis (CO)
Number of subjects: 30
Study: 33978989

Group type: EXPERIMENTAL
Intervention: Veteran peer telephone motivational coaching (4 sessions)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Veteran peer telephone motivational coaching
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control (veteran peer-delivered MH results and referrals without motivational coaching)
Number of subjects: 272
Study: 32843086

Group type: EXPERIMENTAL
Intervention: Third scheduled dose of human monovalent rotavirus vaccine (Rotarix)
Number of subjects: 1000
Study: 35941568

Group type: EXPERIMENTAL
Intervention: Combined clinical‐radiomic model
Number of subjects: 590

Group type: COMPARATOR
Intervention: Clinical model alone
Number of subjects: 590
Study: 34459213

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 5988

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study: 32886932

Group type: EXPERIMENTAL
Intervention: 35 mg TMZ-modified release
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 70 mg TMZ-modified release
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 105 mg TMZ-modified release
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All doses of TMZ-modified release
Number of subjects: 18
Study: 34400031

Group type: EXPERIMENTAL
Intervention: RME Day group (relative motion extension orthosis for day wear and an overnight wrist-hand-finger orthosis)
Number of subjects: 32

Group type: COMPARATOR
Intervention: RME 24-Hr group (relative motion extension orthosis to be worn continuously)
Number of subjects: 32
Study: 33880860

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment, intradermal and subdermal injection weekly for 4-6 sessions.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment (compression and dressing) for chronic venous leg ulcers.
Number of subjects: 80
Study: 33292924

Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Early structured physiotherapy with a steroid injection
Number of subjects: 503
Study: 36307642

Group type: EXPERIMENTAL
Intervention: FHH platform (immediate arm)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Electronic medical record (EMR) (control arm)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: PCP risk‐concordant action (both arms)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Risk‐concordant screening test completion (both arms)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Recommendation for genetic consultation (immediate arm)
Number of subjects: 505

Group type: COMPARATOR
Intervention: Recommendation for genetic consultation (control arm)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Referral for genetic consultation (both arms)
Number of subjects: 505
Study: 32909326

Group type: EXPERIMENTAL
Intervention: Sour tea supplementation (450 mg capsule daily for 8 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (capsule daily for 8 weeks)
Number of subjects: 70
Study: 32029409

Group type: COMPARATOR
Intervention: SL-PLUS™
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SL-PLUS MIA™
Number of subjects: 80
Study: 34303591

Group type: EXPERIMENTAL
Intervention: Partial primary closure (PPC) technique applied to 46 patients
Number of subjects: 96

Group type: COMPARATOR
Intervention: Karydakis flap (KF) technique applied to 50 patients
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Partial primary closure (PPC) technique
Number of subjects: 96

Group type: COMPARATOR
Intervention: Karydakis flap (KF) technique
Number of subjects: 96
Study: 33684370

Group type: EXPERIMENTAL
Intervention: TPEx regimen (docetaxel 75 mg/m2, cisplatin 75 mg/m2, cetuximab 400 mg/m2 on day 1 of cycle 1 and 250 mg/m2 weekly thereafter)
Number of subjects: 541

Group type: COMPARATOR
Intervention: EXTREME regimen (fluorouracil 4000 mg/m2 on days 1-4, cisplatin 100 mg/m2 on day 1, cetuximab 400 mg/m2 on day 1 of cycle 1 and 250 mg/m2 weekly thereafter)
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: TPEx regimen
Number of subjects: 541

Group type: COMPARATOR
Intervention: EXTREME regimen
Number of subjects: 541
Study: 34098026

Group type: EXPERIMENTAL
Intervention: Joyful music
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Fearful music
Number of subjects: 27

Group type: COMPARATOR
Intervention: No music
Number of subjects: 27
Study: 35655124

Group type: EXPERIMENTAL
Intervention: Purple grape juice supplementation
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 47
Study: 32083490

Group type: EXPERIMENTAL
Intervention: LBPT tablet
Number of subjects: 0
Study: 35837972

Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in the retromuscular position around the stoma site
Number of subjects: 232

Group type: COMPARATOR
Intervention: No mesh
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Prophylactic mesh
Number of subjects: 232
Study: 33683433

Group type: EXPERIMENTAL
Intervention: Virtual reality exposure prior to surgery
Number of subjects: 126

Group type: COMPARATOR
Intervention: No virtual reality exposure (control group)
Number of subjects: 126
Study: 32103423

Group type: EXPERIMENTAL
Intervention: Refutation text
Number of subjects: 97

Group type: COMPARATOR
Intervention: Dyslexia Basics text
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Delayed posttest (both groups)
Number of subjects: 97